1Cribier A,Eltchaninoff H,Bash A,et al.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis:first human case description.Circulation,2002,106:3006-3008.
2Holmes DR Jr,Mack MJ,Kaul S,et al.2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.J Am Coll Cardiol,2012,59:1200-1254.
3Vahanian A,Alfieri O,Andreotti F,et al.Guidelines on the management of valvular heart disease(version 2012):the joint task force on the management of valvular heart disease of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS).Eur Heart J,2012,33:2451-2496.
4Nishimura RA,Otto CM,Bonow RO,et al.2014 AHA/ACC guideline for the management of patients with valvular heart disease:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2014,63:2438-2488.
5Leon MB,Smith CR,Mack M,et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med,2010,363:1597-1607.
6Stewart BF,Siscovick D,Lind BK,et al.Clinical factors associated with calcific aortic valve disease:Cardiovascular Health Study.J Am Coll Cardiol,1997,29:630-634.
7Otto CM,Lind BK,Kitzman DW,et al.Association of aorticvalve sclerosis with cardiovascular mortality and morbidity in the elderly.N Engl J Med,1999,341:142-147.
9Pan W,Zhou D,Cheng L,et al.Candidates for transcatheter aortic valve implantation may be fewer in China.Int J Cardiol,2013,168:e133-134.
10Pan W,Zhou D,Cheng L,et al.Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population:implications for transcatheter aortic valve replacement.Int J Cardiol,2015,201:547-548.
